Retatrutide , a triple agonist targeting GLP-1, GIP, and glucagon receptors, showed up to 24% weight loss in phase 2 trials
When to Seek Medical Advice About How You Are Feeling Seek emergency care for signs of anaphylaxis or severe abdominal pain suggesting pancreatitis
Staying well hydrated helps the appetite-suppressing effects of retatrutide work optimally and prevents false hunger signals from being confused with thirst
The GLP-1 Research Generation Map The GLP-1 research peptide category has evolved rapidly through three distinct generations of compounds, each adding additional receptor targets to expand the metabolic research toolkit
On the other hand, Liraglutide, which requires daily injections, may be more suited to patients who need more immediate effects due to its shorter half-life but are comfortable with daily injections